SPRY Historical Earnings image   This SPRY historical earnings page last updated 4/12/2024
SPRY Historical Revenue
PeriodHistorical Earnings DateGAAP
Q4 20233/21/2024NA
Q3 202311/9/2023NA
SPRY Historical Earnings EPS
PeriodHistorical Earnings DateGAAP
Q4 20233/21/2024-0.070
Q3 202311/9/2023-0.160
Quotes delayed 20 minutes

Email EnvelopeFree SPRY Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
ARS Pharmaceuticals (SPRY) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

SQL Historical Earnings
SQZ Historical Earnings
SRDX Historical Earnings
SRGA Historical Earnings
SRNE Historical Earnings
SRPT Historical Earnings
SRRA Historical Earnings
SRRK Historical Earnings
SRTS Historical Earnings
SSKN Historical Earnings
What was the record high SPRY historical earnings result?
In terms of earnings or revenue, what is the best SPRY historical earnings result that ARS Pharmaceuticals has ever posted, and when?

✔️Accepted answer: Within our data set, the highest SPRY historical earnings result was set in Q4 2023, when ARS Pharmaceuticals posted results of -0.070/share. The most successful revenue quarter within our data set was Q4 2023 when ARS Pharmaceuticals reported revenue of NA.

What was the lowest ARS Pharmaceuticals historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest SPRY has reported, and when?

✔️Accepted answer: Within our data set, the lowest SPRY historical earnings result was set in Q3 2023, when ARS Pharmaceuticals posted results of -0.160/share. The smallest revenue quarter within our data set was Q4 2023 when ARS Pharmaceuticals reported revenue of NA.

On this page we presented the SPRY historical earnings date information for ARS Pharmaceuticals. Reviewing that SPRY Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q4 2023, when SPRY posted gaap of -0.070/share. Meanwhile the lowest SPRY historical earnings result was in Q3 2023, when SPRY posted gaap of -0.160/share. Moving to ARS Pharmaceuticalss historical revenue numbers, the largest revenue quarter in our data set was seen in Q4 2023 when SPRY reported NA in revenue, while the smallest revenue quarter was Q4 2023 when SPRY reported NA in revenue.

For self directed investors doing their due diligence on SPRY or any other given stock, their research can benefit from looking into all of the ARS Pharmaceuticals historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into ARS Pharmaceuticals historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for SPRY. Thanks for visiting, and the next time you need to research SPRY historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: SPRT Options Chain, Funds Holding TVC, Funds Holding FTF.

 

SPRY Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.